Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
21.54
-0.97 (-4.31%)
At close: May 15, 2026, 4:00 PM EDT
21.13
-0.41 (-1.90%)
After-hours: May 15, 2026, 7:32 PM EDT

Alamar Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024
Period Ending
May '26 Dec '25 Dec '24
Debt / Equity Ratio
1.830.520.31
Debt / EBITDA Ratio
--1.51-0.71
Debt / FCF Ratio
--0.70-0.57
Net Debt / Equity Ratio
-0.23-0.070.35
Net Debt / EBITDA Ratio
--0.421.00
Net Debt / FCF Ratio
--0.190.80
Asset Turnover
-0.510.17
Inventory Turnover
-1.231.15
Quick Ratio
3.501.805.18
Current Ratio
5.883.996.43
Return on Equity (ROE)
--33.57%-46.34%
Return on Assets (ROA)
--22.14%-33.16%
Return on Invested Capital (ROIC)
--44.56%-89.38%
Return on Capital Employed (ROCE)
--25.15%-37.29%
Buyback Yield / Dilution
-2.88%-
Total Shareholder Return
-2.88%-
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q